Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG)

Summary

The purpose of the protocol is to evaluate the correlation between plasma lanreotide levels and Growth Hormone (GH)/Insulin Like Growth Factor 1 (IGF-1) dynamics and clinical improvement in patients with acromegaly treated with lanreotide Autogel (Somatuline ATG)

Timeline

Start

2008-05

Primary completion

2008-12

Completion

2008-12

Drugs

Indications